Dietary n-3 fatty acids attenuate cardiac allograft vasculopathy via activating peroxisome proliferator-activated receptor-γ

Pediatric Transplantation

Volumn 12, Issue 5, 2008, Pages 550-556

  Rong, Yin ^a   Hairong, Huang ^a   Junwen, Zhang ^a   Jiaquan, Zhu ^b   Hua, Jing ^a   Zhongdong, Li ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Allograft vasculopathy; Cardiac transplantation; Chemokine; Fish oil; PPAR

Indexed keywords

CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CXCR3; CYCLOSPORIN A; DOCOSAHEXAENOIC ACID; GAMMA INTERFERON INDUCIBLE PROTEIN 10; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; OMEGA 3 FATTY ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; CCR2 PROTEIN, HUMAN; CHEMOKINE; CHEMOKINE RECEPTOR; FISH OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIAC ALLOGRAFT VASCULOPATHY; CARDIAC GRAFT REJECTION; CONTROLLED STUDY; DNA BINDING; DOWN REGULATION; DRUG MEGADOSE; HEART TRANSPLANTATION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; ISOGRAFT; LOW DRUG DOSE; MACROPHAGE; MALE; MONONUCLEAR CELL; NONHUMAN; PROTEIN EXPRESSION; RAT; T LYMPHOCYTE; ALLOTRANSPLANTATION; ANIMAL; DIET; GENE EXPRESSION REGULATION; METABOLISM; METHODOLOGY; VASCULAR DISEASE;

ANIMALS; CHEMOKINES; DIET; FATTY ACIDS, OMEGA-3; FISH OILS; GENE EXPRESSION REGULATION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; NF-KAPPA B; PPAR GAMMA; RATS; RECEPTORS, CCR2; RECEPTORS, CHEMOKINE; TRANSPLANTATION, HOMOLOGOUS; VASCULAR DISEASES;

EID: 55949100120     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2007.00849.x     Document Type: Article

References (33)

1. RAMZY D, RAO V, BRAHM J, MIRIUKA S, DELGADO D, ROSS HJ. Cardiac allograft vasculopathy: A review. Can J Surg 2005: 48: 319-327.
2. HERTZ MI, TAYLOR DO, TRULOCK EP, et al. The registry of the international society for heart and lung transplantation: Nineteenth official report-2002. J Heart Lung Transplant 2002: 21: 950-970.
3. CLARK RB. The role of PPARs in inflammation and immunity. J Leukoc Biol 2002: 71: 388-400.
4. BROWN JD, PLUTZKY J. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets. Circulation 2007: 115: 518-533.
5. BABAEV VR, YANCEY PG, RYZHOV SV, et al. Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice. Arterioscler Thromb Vasc Biol 2005: 25: 1647-1653.
6. CHEN Y, GREEN SR, Ho J, Li A, ALMAZAN F, QUEHENBERGER O. The mouse CCR2 gene is regulated by two promoters that are responsive to plasma cholesterol and peroxisome proliferator- activated receptor gamma ligands. Biochem Biophys Res Commun 2005: 332: 188-193.
7. HAN KH, CHANG MK, BOULLIER A, et al. Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. J Clin Invest 2000: 106: 793-802.
8. KOSUGE H, HARAGUCHI G, KOGA N, MAEJIMA Y, SUZUKI J, ISOBE M. Pioglitazone prevents acute and chronic cardiac allograft rejection. Circulation 2006: 113: 2613-2622.
9. DECKELBAUM RJ, WORGALL TS, SEO T. n-3 fatty acids and gene expression. Am J Clin Nutr 2006: 83(Suppl. 6): 1520S-1525S.
10. SARRIS GE, MITCHELL RS, BILLINGHAM ME, GLASSON JR, CAHILL PD, MILLER DC. Inhibition of accelerated cardiac allograft arteriosclerosis by fish oil. J Thorac Cardiovasc Surg 1989: 97: 841-854.
11. GRIMMINGER F, GRIMM H, FUHRER D, et al. Omega-3 lipid infusion in a heart allotransplant model. Shift in fatty acid and lipid mediator profiles and prolongation of transplant survival. Circulation 1996: 93: 365-371.
12. ALEXANDER JW, VALENTE JF, GREENBERG NA, et al. Dietary omega-3 and omega-9 fatty acids uniquely enhance allograft survival in cyclosporine-treated and donor-specific transfusiontreated rats. Transplantation 1998: 65: 1304-1309.
13. MA H, WANG J, WANG J, LI Y, LI J. Fish oil ameliorates the allograft arteriosclerosis of intestine on rats. Pediatr Transplant 2007: 11: 173-179.
14. ITOH T, MUROTA I, YOSHIKAI K, YAMADA S, YAMAMOTO K. Synthesis of docosahexaenoic acid derivatives designed as novel PPARgamma agonists and antidiabetic agents. Bioorg Med Chem 2006: 14: 98-108.
15. DESVERGNE B, WAHLI W. Peroxisome proliferator-activated receptors: Nuclear control of metabolism. Endocr Rev 1999: 20: 649-688.
16. LI H, RUAN XZ, POWIS SH, et al. EPA and DHA reduce LPSinduced inflammation responses in HK-2 cells: Evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005: 67: 867-874.
17. ONO K, LINDSEY ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969: 57: 225-229.
18. AKASHI S, SHO M, KASHIZUKA H, et al. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection. Transplantation 2005: 80: 378-384.
19. YUN JJ, WHITING D, FISCHBEIN MP, et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 2004: 109: 932-937.
20. HANCOCK WW. Chemokine receptor-dependent alloresponses. Immunol Rev 2003: 196: 37-50.
21. DELERIVE P, FRUCHART JC, STAELS B. Peroxisome proliferatoractivated receptors in inflammation control. J Endocrinol 2001: 169: 453-459.
22. MARX N, KEHRLE B, KOHLHAMMER K, et al. PPAR activators as antiinflammatory mediators in human T lymphocytes: Implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ Res 2002: 90: 703-710.
23. ZHANG X, WANG JM, GONG WH, MUKAIDA N, YOUNG HA. Differential regulation of chemokine gene expression by 15- deoxy-delta 12,14 prostaglandin J2. J Immunol 2001: 166: 7104-7111.
24. MARX N, MACH F, SAUTY A, et al. Peroxisome proliferatoractivated receptor-gamma activators inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells. J Immunol 2000: 164: 6503-6508.
25. ZHAO G, ETHERTON TD, MARTIN KR, et al. Anti-inflammatory effects of polyunsaturated fatty acids in THP-1 cells. Biochem Biophys Res Commun 2005: 336: 909-917.
26. HORIGUCHI K, KITAGAWA-SAKAKIDA S, SAWA Y, et al. Selective chemokine and receptor gene expressions in allografts that develop transplant vasculopathy. J Heart Lung Transplant 2002: 21: 1090-1100.
27. YUN JJ, FISCHBEIN MP, LAKS H, et al. Early and late chemokine production correlates with cellular recruitment in cardiac allograft vasculopathy. Transplantation 2000: 69: 2515-2524.
28. ZHANG M, HAGIWARA S, MATSUMOTO M, et al. Effects of eicosapentaenoic acid on the early stage of type 2 diabetic nephropathy in KKA(y)/Ta mice: Involvement of anti-inflammation and antioxidative stress. Metabolism 2006: 55: 1590- 1598.
29. EL SEWEIDY MM, EL-SWEFY SE, ABDALLAH FR, HASHEM RM. Dietary fatty acid unsaturation levels, lipoprotein oxidation and circulating chemokine in experimentally induced atherosclerotic rats. J Pharm Pharmacol 2005: 57: 1467-1474.
30. NANJI AA, JOKELAINEN K, FOTOUHINIA M, et al. Increased severity of alcoholic liver injury in female rats: Role of oxidative stress, endotoxin, and chemokines. Am J Physiol Gastrointest Liver Physiol 2001: 281: G1348-G1356.
31. TANAKA T, FUKUNAGA Y, ITOH H, et al. Therapeutic potential of thiazolidinediones in activation of peroxisome proliferatoractivated receptor gamma for monocyte recruitment and endothelial regeneration. Eur J Pharmacol 2005: 508: 255-265.
32. MELTER M, EXENI A, REINDERS ME, et al. Expression of the chemokine receptor CXCR3 and its ligand IP-10 during human cardiac allograft rejection. Circulation 2001: 104: 2558- 2564.
33. HANCOCK WW, GAO W, CSIZMADIA V, FAIA KL, SHEMMERI N, LUSTER AD. Donor-derived IP-10 initiates development of acute allograft rejection. J Exp Med 2001: 193: 975-980. Yin et al.